Entrada Therapeutics (TRDA) EPS (Basic) (2020 - 2026)
Entrada Therapeutics' (TRDA) quarterly EPS (Basic) came in at -$0.95 in Q1 2026, down 124.76% year-on-year from $3.83 in Q1 2025, and little changed quarter-over-quarter from -$0.95 in Q4 2025.
Entrada Therapeutics (TRDA) EPS (Basic) (2020 - 2026) Analysis & Trends
Entrada Therapeutics' EPS (Basic) history runs 7 years deep, the most recent figure standing at -$0.95 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 124.76% year-over-year to -$0.95 in Q1 2026; TTM through Mar 2026 was -$3.97, a 759.36% decrease from a year earlier, with the FY2025 full-year figure at -$3.47, down 297.49% from the prior year.
- EPS (Basic) held at -$0.95 in Q1 2026 per TRDA's latest filing, from -$0.95 in the prior quarter.
- Across five years, EPS (Basic) topped out at $1.61 in Q2 2024 and bottomed at -$1.06 in Q3 2025.
- The 5-year median for EPS (Basic) is -$0.69 (2022), against an average of -$0.33.
- Across the five-year window, EPS (Basic) soared 440.25% in 2024 and slumped 3223.17% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$0.79 in 2022, then jumped by 63.47% to -$0.29 in 2023, then surged by 110.54% to $0.03 in 2024, then slumped by 3223.17% to -$0.95 in 2025, then retreated by 0.26% to -$0.95 in 2026.
- Per Business Quant, the three latest TRDA EPS (Basic) figures stand at -$0.95 (Q1 2026), -$0.95 (Q4 2025), and -$1.06 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Entrada Therapeutics | 245.16 Mn | 245.16 Mn | - | -0.95 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.95 |
| Dec 31, 2025 | -0.95 |
| Sep 30, 2025 | -1.06 |
| Jun 30, 2025 | -1.04 |
| Mar 31, 2025 | -0.42 |
| Dec 31, 2024 | 0.03 |
| Sep 30, 2024 | -0.35 |
| Jun 30, 2024 | 1.61 |
| Mar 31, 2024 | 0.70 |
| Dec 31, 2023 | -0.29 |
| Sep 30, 2023 | 1.07 |
| Jun 30, 2023 | -0.78 |
| Mar 31, 2023 | -0.21 |
| Dec 31, 2022 | -0.79 |
| Sep 30, 2022 | -0.80 |
| Jun 30, 2022 | -0.74 |
| Mar 31, 2022 | -0.69 |
| Dec 31, 2021 | -7.56 |
| Sep 30, 2021 | -23.36 |
| Jun 30, 2021 | -7.56 |